Better DME outcomes seen with intravitreal pegaptanib therapy

12/3/2012 |

Intravitreal pegaptanib sodium treatment correlated with significant improvements in foveal thickness in diabetes patients with clinically significant macular edema, a study found. Researchers also noted enhanced macular sensitivity, color discrimination and best-corrected visual acuity in patients. The results appear in the British Journal of Clinical Pharmacology.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA